Physician

Faris Hawit, M.D.

According to 2025 Medicare claims, Faris Hawit, M.D. (NPI: 1346380896) practices dermatology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from Calvert, MD. This provider's primary affiliated billing organization is CALVERT DERMATOLOGY, LLC (NPI: 1295875763; TIN: 208304317) and primary practice location at 20678-1540.

Hawit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,400 traditional Medicare patients, billed 10,437 HCPCS/CPT codes, and received $885,375 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 735 prescription claims across 389 beneficiaries totaling $23,010 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $55,322 to $23,010. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$443K$885K2015 Medicare payment: $558,746 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $648,787 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $646,684 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $697,638 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $819,632 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $790,653 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $866,925 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $875,748 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $828,149 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $885,375 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2759,706$558,746
20161,32310,442$648,787
20171,25710,408$646,684
20181,2069,927$697,638
20191,24311,529$819,632
20201,14510,369$790,653
20211,16910,834$866,925
20221,26210,410$875,748
20231,2769,537$828,149
20241,40010,437$885,375

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$55K2015 Drug cost: $55,322 (USD; Tot_Drug_Cst)2016 Drug cost: $46,045 (USD; Tot_Drug_Cst)2017 Drug cost: $35,202 (USD; Tot_Drug_Cst)2018 Drug cost: $31,138 (USD; Tot_Drug_Cst)2019 Drug cost: $26,397 (USD; Tot_Drug_Cst)2020 Drug cost: $25,881 (USD; Tot_Drug_Cst)2021 Drug cost: $25,681 (USD; Tot_Drug_Cst)2022 Drug cost: $24,355 (USD; Tot_Drug_Cst)2023 Drug cost: $22,217 (USD; Tot_Drug_Cst)2024 Drug cost: $23,010 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015236465$55,322
2016273592$46,045
2017283526$35,202
2018264533$31,138
2019336617$26,397
2020305600$25,881
2021322619$25,681
2022283536$24,355
2023310612$22,217
2024389735$23,010

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks338433$488
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more497571$64
11102Biopsy of related skin growth, first growth412561$60
17000Destruction of precancer skin growth, 1 growth587778$35
17003Destruction of precancer skin growth, 2-14 growths5003,158$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil882,336$5,672
Clobetasol PropionateClobetasol Propionate32856$2,424
ImiquimodImiquimod462,387$1,790
Triamcinolone AcetonideTriamcinolone Acetonide984,081$1,328
MetronidazoleMetronidazole24756$1,247

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Faris Hawit, M.D.?

Tedicare shows public-source Medicare data for Faris Hawit, M.D. (NPI 1346380896), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Faris Hawit, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Faris Hawit, M.D.?

Faris Hawit, M.D. is linked to CALVERT DERMATOLOGY, LLC (billing NPI 1295875763) in the available physician profile data.

Does Faris Hawit, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.